Engineers Gate Manager’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
28,915
+7,410
+34% +$56.2K ﹤0.01% 1801
2026
Q1
$155K Buy
+21,505
New +$138K ﹤0.01% 1962
2025
Q1
Sell
-21,622
Closed -$86.5K 2547
2024
Q4
$86.5K Buy
+21,622
New +$119K ﹤0.01% 2018
2022
Q2
Sell
-760
Closed -$14K 2229
2022
Q1
$14K Buy
+760
New +$13.4K ﹤0.01% 1782
2021
Q2
Sell
-2,613
Closed -$217K 1982
2021
Q1
$217K Buy
+2,613
New +$289K 0.01% 1555
2020
Q3
Sell
-1,076
Closed -$47K 1950
2020
Q2
$47K Buy
+1,076
New +$44.7K ﹤0.01% 1642
2019
Q3
Sell
-1,563
Closed -$135K 1587
2019
Q2
$135K Buy
+1,563
New +$170K 0.01% 1031
2018
Q2
Sell
-1,556
Closed -$175K 1153
2018
Q1
$175K Buy
+1,556
New +$525K 0.01% 743

Other funds holding SLDB

Engineers Gate Manager's SLDB Position: Q2 2026 in Review

Engineers Gate Manager increased its Solid Biosciences (SLDB) stake by 34% in Q2 2026, buying an estimated $56.2K and bringing the position to 28,915 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1801.

Engineers Gate Manager first reported a position in SLDB in Q1 2018 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Engineers Gate Manager held 28,915 shares of Solid Biosciences worth $289K as of Q2 2026.
  • Engineers Gate Manager bought 7,410 Solid Biosciences shares in Q2 2026, an estimated $56.2K.
  • Solid Biosciences made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1801 holding.
  • Engineers Gate Manager first reported a position in Solid Biosciences in Q1 2018 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.